| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e913dde0912f7ac734d9bf09a66c680e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aa5df7d19a35b2c25bd15a973674e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a102b2c4d6b777a6a81adf58ddb5a017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63257c21c6aa48a0eb5692cef29c9385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1643f360f967a1ceea22b92a454d50f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c913ef1d08792f0c1c08aa92606615e |
| publicationDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2751132-C1 |
| titleOfInvention |
Application of recombinant analogue of human protein slurp-1 in combination with cytostatics or proteasome inhibitor products for inhibiting growth of carcinomas |
| abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to the field of biotechnology, specifically to a combined application of pharmaceuticals from the groups of cytostatics or proteasome inhibitors with a recombinant analogue of the protein SLURP-1 with SEQ ID NO:1 for inhibiting the growth of carcinomas, and can be used in medicine.EFFECT: proposed method allows increasing effectiveness of pharmaceuticals from the groups of cytostatics and proteasome inhibitors and lowering concentrations thereof required to suppress tumour growth.2 cl, 2 dwg, 2 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2792364-C1 |
| priorityDate |
2020-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |